An­oth­er four IPOs com­plete busy week as biotech raise con­tin­ues to match 2020's record pace

Ed­i­tor’s note: In­ter­est­ed in fol­low­ing bio­phar­ma’s fast-paced IPO mar­ket? You can book­mark our IPO Track­er here.

One of the busiest IPO weeks of the year has capped off with an­oth­er four biotechs ex­pect­ed to make their pub­lic de­buts Fri­day.

Af­ter Lyell, Verve and Mol­e­c­u­lar Part­ners all priced ear­li­er in the week, ATAI Life Sci­ences, Cen­tu­ry Ther­a­peu­tics, Am­brx Bio­phar­ma and Cyteir Ther­a­peu­tics each fol­lowed suit with nine-fig­ure rais­es af­ter mar­ket close Thurs­day. All that ef­fort has dri­ven the com­bined biotech IPO raise close to $9 bil­lion, per the End­points News tal­ly.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN